Authors: Monica Gunetti, Simone Tomasi, Alessandro Giammò, Marina Boido, Deborah Rustichelli, Katia Mareschi, Edoardo Errichiello, Maurizio Parola, Ivana Ferrero, Franca Fagioli, Alessandro Vercelli, Roberto Carone
DOI: 10.1371/journal.pone.0045538
Abstract Summary
Researchers tested mesenchymal stem cells (MSCs) as a potential treatment for urinary incontinence, which affects 30% of women and 15% of men over 60. When transplanted near the urethral sphincter, MSCs survived long-term, migrated into muscle tissue, and showed no safety concerns or tumor formation.
Why Brain? 🧠
Bone marrow stem cells show promise for treating urinary incontinence by safely surviving in pelvic muscles without immunosuppression, migrating to muscle fibers and nerve junctions.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.
